Initial Safety Analysis of CapeOx for Elderly Patients With Advanced Gastric Cancer Patients: A Phase II Trial

Initial Safety Analysis of CapeOx for Elderly Patients With Advanced Gastric Cancer Patients: A Phase II Trial

BACKGROUND: Safety of combination chemotherapy using platinum and fluorouracil has not been evaluated adequately for advanced gastric cancer (AGC) in elderly patients. PATIENTS AND METHODS: We initiated a phase II study to evaluate the efficacy and safety of capecitabine plus oxaliplatin (CapeOX) as...

Full description

Bibliographic Details
Main Authors: Chin, K. (Author), Goto, M. (Author), Hosaka, H. (Author), Ichikawa, W. (Author), Imamura, H. (Author), Ishizuka, N. (Author), Kawabata, R. (Author), Nagashima, F. (Author), Nakamura, M. (Author), Saitou, S.O (Author), Saotome, T. (Author), Shindo, Y. (Author), Shiraishi, T. (Author), Takahari, D. (Author), Yabusaki, H. (Author), Yamaguchi, K. (Author), Yamamoto, W. (Author)
Format: Article
Language:English
Published: NLM (Medline) 2022
Subjects:
capecitabine
chemotherapy
elderly
Gastric cancer
oxaliplatin
phase 2 trial
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items